Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin: Toxicity, dosimetry, and therapeutic response

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Chemoradionuclide therapy with <sup>186</sup>Re-labeled liposomal doxorubicin: Toxicity, dosimetry, and therapeutic response'. Together they form a unique fingerprint.

Medicine & Life Sciences